Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Glasdegib maleate

EU orphan designation number: EU/3/17/1923   
Active ingredient: Glasdegib maleate
Indication: Treatment of acute myeloid leukaemia
Sponsor: Pfizer Europe MA EEIG
Boulevard de la Plaine 17, 1050 Bruxelles, Belgique/ Pleinlaan 17, 1050 Brussel, België

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
18/10/2017 Orphan designation EMA/OD/106/17 (2017)7056 of 16/10/2017
21/11/2018 Transfer of orphan designation EMA/OD/106/17/T/01 (2018)7839 of 19/11/2018